Spirometry, Static Lung Volumes, and Diffusing Capacity

References

1. 1.↵
   1. Pellegrino R,
   2. Viegi G,
   3. Brusasco V,
   4. Crapo RO,
   5. Burgos F,
   6. Casaburi R,
   7. et al

   . Interpretative strategies for lung function tests. Eur Respir J 2005;26(5):948–968.

   OpenUrlFREE Full Text
2. 2.↵
   1. Aaron SD,
   2. Dales RE,
   3. Cardinal P

   . How accurate is spirometry at predicting restrictive pulmonary impairment? Chest 1999;115(3):869–873.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Glady CA,
   2. Aaron SD,
   3. Lunau M,
   4. Clinch J,
   5. Dales RE

   . A spirometry-based algorithm to direct lung function testing in the pulmonary function laboratory. Chest 2003;123(6):1939–1946.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Crapo RO,
   2. Morris AH,
   3. Gardner RM

   . Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981;123(6):659–664.

   OpenUrlPubMedWeb of Science
5. 5.↵
   1. Knudson R,
   2. Lebowitz M,
   3. Holberg C,
   4. Burrows B

   . Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127(6):725–734.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.
   1. Enright P,
   2. Kronmal R,
   3. Higgins M,
   4. Schenker M,
   5. Haponik EF

   . Spirometry reference values for women and men 65 to 85 years of age. Am Rev Respir Dis 1993;147(1):125–133.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Hankinson JL,
   2. Odencrantz JR,
   3. Fedan KB

   . Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159(1):179–187.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Stanojevic S,
   2. Wade A,
   3. Stocks J,
   4. Hankinson J,
   5. Coates AL,
   6. Pan H,
   7. et al

   . Reference ranges for spirometry across all ages. Am J Respir Crit Care Med 2008;177(3):253–260.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Quanjer PH,
   2. Stanojevic S,
   3. Cole TJ,
   4. Baur X,
   5. Hall GL,
   6. Culver BH,
   7. et al

   . Multi-ethnic reference values for spirometry for the 3-95 year age range: the global lung function 2012 equations. Eur Respir J 2012;40(6):1324–1343.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Miller A,
    2. Enright PL

    . PFT Interpretive strategies: American Thoracic Society/European Respiratory Society 2005 guideline gaps. Respir Care 2012;57(1):127–133.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Crapo R,
    2. Morris A,
    3. Clayton P,
    4. Nixon CR

    . Lung volumes in healthy nonsmoking adults. Bull Europ Physiopath Resp 1982;18(3):419–425.

    OpenUrlPubMedWeb of Science
12. 12.↵
    1. Cummings SR,
    2. Bates D,
    3. Black DM

    . Clinical use of bone densitometry: scientific review. JAMA 2002;288(5):1889–1897.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Vaz Fragoso CA,
    2. Gill T

    . Respiratory Impairment and the aging lung: a novel paradigm for assessing pulmonary function. J Gerontol Med Sci 2012;67(3):264–275.

    OpenUrlPubMedWeb of Science
14. 14.↵
    1. Vaz Fragoso CA,
    2. Enright PL,
    3. McAvay G,
    4. Van Ness PH,
    5. Gill TM

    . Frailty and respiratory impairment in older persons. Am J Med 2012;125(1):79–86.

    OpenUrlCrossRefPubMed
15. 15.
    1. Vaz Fragoso CA,
    2. Gill TM,
    3. McAvay G,
    4. Quanjer PH,
    5. Van Ness PH,
    6. Concato J

    . Respiratory impairment in older persons: when less means more. Am J Med 2013;126(1):49–57.

    OpenUrlCrossRefPubMed
16. 16.
    1. Vaz Fragoso CA,
    2. McAvay G,
    3. Gill TM,
    4. Concato J,
    5. Quanjer PH,
    6. Van Ness PH

    . Ethnic differences in respiratory impairment. Thorax 2014;69(1):55–62.

    OpenUrlAbstract/FREE Full Text
17. 17.
    1. Marcus BS,
    2. McAvay G,
    3. Gill TM,
    4. Vaz Fragoso CA

    . Respiratory symptoms, spirometric respiratory impairment, and respiratory disease in middle- and older-aged persons. J Am Geriatr Soc 2015;63(2):251–257.

    OpenUrl
18. 18.↵
    1. Vaz Fragoso CA,
    2. McAvay G,
    3. Van Ness PH,
    4. Casaburi R,
    5. Jensen RL,
    6. MacIntyre N,
    7. et al

    . Phenotype of spirometric impairment in an aging population. Am J Respir Crit Care Med 2016;193(7):727–735.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Vaz Fragoso CA,
    2. McAvay G,
    3. Van Ness PH,
    4. Casaburi R,
    5. Jensen RL,
    6. MacIntyre N,
    7. et al

    . Phenotype of normal spirometry in an aging population. Am J Respir Crit Care Med 2015;192(7):817–825.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Miller MR,
    2. Pedersen OF

    . New concepts for expressing forced expiratory volume in 1 s arising from survival analysis. Eur Respir J 2010;35(4):873–882.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. MacIntyre N,
    2. Crapo RO,
    3. Viegi G,
    4. Johnson DC,
    5. van der Grinten CPM,
    6. Brusasco V,
    7. et al

    . Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005;26(4):720–735.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Miller MR,
    2. Hankinson J,
    3. Brusasco V,
    4. Burgos F,
    5. Casaburi R,
    6. Coates A,
    7. et al

    . Standardisation of spirometry. Eur Respir J 2005;26(2):319–338.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Wanger W,
    2. Clausen JL,
    3. Coates A,
    4. Pedersen OF,
    5. Brusasco V,
    6. Burgos F,
    7. et al

    . Standardisation of the measurement of lung volumes Eur Respir J 2005;26(3):511–522.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Flesch JD,
    2. Dine CJ

    . Lung volumes: measurement, clinical use, and coding. Chest 2012;142(2):506–510.

    OpenUrlPubMed
25. 25.↵
    1. Allen SC,
    2. Yeung P

    . Inability to draw intersecting pentagons as a predictor of unsatisfactory spirometry technique in elderly hospital inpatients. Age Ageing 2006;35(3):304–316.

    OpenUrlCrossRefPubMedWeb of Science
26. 26.↵
    1. Gershon A,
    2. Croxford R,
    3. Calzavara A

    . Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease. JAMA Intern Med 2013;173(13):1175–1185.

    OpenUrlPubMed
27. 27.↵
    1. Pellegrino R,
    2. Antonelli A,
    3. Mondino M

    . Bronchodilator testing: an endless story. Eur Respir J 2010;35(5):952–954.

    OpenUrlFREE Full Text
28. 28.↵
    1. Vaz Fragoso CA,
    2. Concato J,
    3. McAvay G,
    4. Yaggi HK,
    5. Van Ness PH,
    6. Gill TM

    . Staging the severity of chronic obstructive pulmonary disease in older persons based on spirometric Z-scores. J Am Geriatr Soc 2011;59(10):1847–1854.

    OpenUrlCrossRefPubMed
29. 29.↵
    1. Vaz Fragoso CA,
    2. Concato J,
    3. McAvay G,
    4. Van Ness PH,
    5. Gill TM

    . Respiratory impairment and COPD hospitalization: a competing risk analysis. Eur Respir J 2012;(1):40:37–44.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    1. O'Donnell DE,
    2. Laveneziana P

    . Physiology and consequences of lung hyperinflation in COPD. Eur Respir Rev 2006;15(100):61–67.

    OpenUrlAbstract/FREE Full Text
31. 31.↵
    1. Casaburi R,
    2. Rennard SI

    . Exercise limitation in chronic obstructive pulmonary disease: the O'Donnell threshold. Am J Respir Crit Care Med 2015;191(8):873–875.

    OpenUrlCrossRefPubMed
32. 32.↵
    1. Friedman GD,
    2. Klatsky AL,
    3. Siegelaub AB

    . Lung function and risk of myocardial infarction and sudden cardiac death. NEJM 1976;294(20):1071–1075.

    OpenUrlCrossRefPubMedWeb of Science
33. 33.
    1. Lee HM,
    2. Le H,
    3. Lee BT,
    4. Lopez VA,
    5. Wong ND

    . Forced vital capacity paired with Framingham risk score for prediction of all-cause mortality. Eur Respir J 2010;36(5):1002–1006.

    OpenUrlAbstract/FREE Full Text
34. 34.
    1. Nakajima K,
    2. Kubouchi Y,
    3. Muneyuki T,
    4. Ebata M,
    5. Equchi S,
    6. Munakata H

    . A possible association between suspected restrictive pattern as assessed by ordinary pulmonary function test and the metabolic syndrome. Chest 2008;134(4):712–718.

    OpenUrlCrossRefPubMedWeb of Science
35. 35.
    1. van der Palen J,
    2. Rea TD,
    3. Manolio TA,
    4. Lumley T,
    5. Newman AB,
    6. Tracy RP,
    7. et al

    . Respiratory muscle strength and the risk of incident cardiovascular events. Thorax 2004;59(12):1063–1067.

    OpenUrlAbstract/FREE Full Text
36. 36.
    1. Steier J,
    2. Lunt A,
    3. Hart N,
    4. Polkey MI,
    5. Moxham J

    . Observational study of the effect of obesity on lung volumes. Thorax 2014;69(8):752–759.

    OpenUrlAbstract/FREE Full Text
37. 37.
    1. Di Bari M,
    2. Chiarlone M,
    3. Matteuzzi D,
    4. Zacchei S,
    5. Pozzi C,
    6. Bellia V,
    7. et al

    . Thoracic kyphosis and ventilatory dysfunction in unselected older persons: an epidemiological study in Dicomano, Italy. J Am Geriatr Soc 2004;52(6):909–915.

    OpenUrlCrossRefPubMedWeb of Science
38. 38.
    1. Sun X-G,
    2. MD,
    3. Hansen JE,
    4. Oudiz RJ,
    5. Wasserman K

    . Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol 2003;41(6):1028–1035.

    OpenUrlFREE Full Text
39. 39.↵
    1. Braun NMT,
    2. Arora NS,
    3. Rochester DF

    . Respiratory muscle and pulmonary function in polymyositis and other proximal myopathies. Thorax 1983;38(8):616–623.

    OpenUrlAbstract/FREE Full Text
40. 40.↵
    1. Laghi F,
    2. Jubran A,
    3. Topeli A,
    4. Fahey PJ,
    5. Garrity ER Jr.,
    6. de Pinto DJ,
    7. Tobin MJ

    . Effect of lung volume reduction surgery on diaphragmatic neuromechanical coupling at 2 years. Chest 2004;125(6):2188–2195.

    OpenUrlCrossRefPubMedWeb of Science
41. 41.↵
    1. Jones SE,
    2. Maddocks M,
    3. Kon SSC,
    4. Canavan JL,
    5. Nolan CM,
    6. Clark AL,
    7. et al

    . Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax 2015;70(3):213–218.

    OpenUrlAbstract/FREE Full Text
42. 42.↵
    1. Vestbo J,
    2. Hurd SS,
    3. Agusti AG,
    4. Jones PW,
    5. Vogelmeier C,
    6. anzueto A,
    7. et al

    . GOLD executive summary. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187(4):347–365.

    OpenUrlCrossRefPubMedWeb of Science
43. 43.↵
    1. Miller MR,
    2. Quanjer PH,
    3. Swanney MP,
    4. Ruppel G,
    5. Enright PL

    . Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients. Chest 2011;139(1):52–59.

    OpenUrlCrossRefPubMedWeb of Science
44. 44.↵
    1. Miller MR,
    2. Pincock AC

    . Predicted values: how should we use them? Thorax 1988;43:265–267.

    OpenUrlFREE Full Text
45. 45.↵
    1. O'Donnell CR,
    2. Bankier AA,
    3. Stiebellehner L,
    4. Reilly JJ,
    5. Brown R,
    6. Loring SH

    . Comparison of plethysmographic and helium dilution lung volumes: which is best for COPD? Chest 2010;137(5):1108–1115.

    OpenUrlCrossRefPubMedWeb of Science
46. 46.↵
    1. Hegewald MJ,
    2. Gallo HM,
    3. Wilson EL

    . Accuracy and quality of spirometry in primary care offices. Ann Am Thorac Soc 2016;13(12):2119–2124.

    OpenUrl
47. 47.↵
    1. Milne JS,
    2. Williamson J

    . Respiratory function tests in older people. Clin Sci 1972;42(3):371–381.

    OpenUrl
48. 48.↵
    1. Miner B,
    2. Tinetti ME,
    3. Van Ness PH,
    4. Han L,
    5. Leo-Summers L,
    6. Newman AB,
    7. et al

    . Dyspnea in community-dwelling older persons: a multifactorial geriatric health condition. J Am Geriatr Soc 2016;64(10):2042–2050.

    OpenUrl